1714147-49-5 Usage
Description
C29H42FN3O7S, also known as S-Desmethyl-S-(2-hydroxy-2-methylpropyl) Rosuvastatin tert-Butyl Ester (Rosuvastatin EP Impurity A T-Butyl Ester), is an intermediate compound in the synthesis of Rosuvastatin (R700500) and related compounds. It is a complex organic molecule with a molecular formula indicating the presence of carbon, hydrogen, fluorine, nitrogen, oxygen, and sulfur atoms.
Uses
Used in Pharmaceutical Industry:
C29H42FN3O7S is used as an intermediate in the synthesis of Rosuvastatin for [application reason]. Rosuvastatin is a widely prescribed medication in the treatment of high cholesterol and related cardiovascular conditions. As an intermediate, C29H42FN3O7S plays a crucial role in the production process, ensuring the availability and effectiveness of this essential drug.
Used in Chemical Research and Development:
C29H42FN3O7S is also used as a research compound in the field of chemical research and development. Its unique structure and properties make it a valuable tool for scientists and researchers working on the development of new pharmaceuticals, particularly in the area of cholesterol management and cardiovascular health. The compound's versatility and potential for modification contribute to its importance in this field.
Check Digit Verification of cas no
The CAS Registry Mumber 1714147-49-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,7,1,4,1,4 and 7 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1714147-49:
(9*1)+(8*7)+(7*1)+(6*4)+(5*1)+(4*4)+(3*7)+(2*4)+(1*9)=155
155 % 10 = 5
So 1714147-49-5 is a valid CAS Registry Number.
1714147-49-5Relevant articles and documents
A kind of rosuvastatin sandbank impurity A preparation method
-
Paragraph 0037; 0038; 0039, (2017/08/26)
The invention relates to the preparation method of a compound (ROSA-1). The method comprises the following steps: under a low temperature, dissolving the compound (ROSO1) into an ether solvent, slowly dripping a strong base ether solution, and after dripping, adding acetone under a low temperature for reaction (refer to the description). The invention firstly discloses the preparation method of a rosuvastatin impurity A, since rosuvastatin and intermediates thereof have more reaction points, a great deal of by-products can be produced during the reaction process, according to the preparation method provided by the invention, the reaction conditions of all steps are optimized, finally, the rosuvastatin impurity A with high purity and HPLC purity higher than 99 percent can be obtained, therefore, the rosuvastatin impurity A can be used as a reference substance for use during the quality research of the rosuvastatin impurity A.
